SLRX MEXC RealStocks
Own real SLRX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 14:52:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Salarius Pharmaceuticals, Inc. (SLRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Salarius Pharmaceuticals, Inc. (SLRX) is currently trading at $-- as of --, -- from the previous close of $--
During today's regular trading session, SLRX has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.
Over the past seven days, Salarius Pharmaceuticals, Inc. (SLRX) moved from $0.66 to $0.84, representing a gain of 28.21% ($0.18).
The stock traded between $0.51 and $0.90 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.30 million shares, up versus the previous seven-day period, indicating higher trading activity.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Salarius Pharmaceuticals, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Salarius Pharmaceuticals, Inc. (SLRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SLRX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SLRX shares and USD.
SLRX Shares to USD
1.00 SLRX shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.